Clinical Trials Directory

Trials / Completed

CompletedNCT03372395

Probiotic Implementation as Help in Solving Vaginal Infections

Lactobacilli Implementation to Restore a Balanced Vaginal Ecosystem: a Promising Solution Against Vaginosis, Vaginitis and HPV Infection

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
117 (actual)
Sponsor
University of Roma La Sapienza · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Over recent years, a growing interest has developed in microbiota and in the concept of maintaining a special balance between Lactobacillus and other bacteria species in order to promote women's well-being. The aim of the study was to confirm that vaginal Lactobacilli long-lasting implementation in women with HPVinfections and concomitant bacterial vaginosis or vaginitis might be able to help in solving the viral infection, by re-establishing the original eubiosis.

Detailed description

A total of 117 women affected by bacterial vaginosis or vaginitis with concomitant HPV infections were enrolled at Department of Gynecological Obstetrics and Urological Sciences, La Sapienza University, Rome, Italy between February 2015 and March 2016. Women were randomized in two groups, standard treatment (metronidazole 500 mg twice a day for 7 days or fluconazole 150 mg orally once a day for 2 consecutive days) plus short-term (3 months) vaginal Lactobacillus implementation (group 1, short probiotics treatment protocol group, n=60) versus the same standard treatment plus long-lasting (6 months) vaginal Lactobacillus rhamnosus BMX 54 administration (group 2, treatment group, n=57).

Conditions

Interventions

TypeNameDescription
OTHERLactobacillus rhamnosus BMX 54Given once a day for 10 days, once every 3 days for 20 days and then once every 5 days for other 2 months in all patients (probiotics implementation for 3 months comprehensively).

Timeline

Start date
2015-02-01
Primary completion
2016-03-01
Completion
2016-04-01
First posted
2017-12-13
Last updated
2017-12-13

Source: ClinicalTrials.gov record NCT03372395. Inclusion in this directory is not an endorsement.